1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
The company has great potential if and when it enters the commercial stage.
Full Article
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
Motley Fool
0 shares
1 views
You might like
Related news coverage
1 Wall Street Analyst Thinks Devon Energy Stock Is Going to $57. Is It a Buy?
Motley Fool
This leading dividend-paying oil stock just beat expectations in the first quarter.
-
1 Wall Street Analyst Thinks Shopify Stock Is Going to $78 Instead of $92. Is It a Buy?
Motley Fool
-
1 Analyst Thinks Caterpillar Stock Is Going to $345. Is It a Buy?
Motley Fool
-
Is Symbotic Stock Going to $53? 1 Wall Street Analyst Thinks So.
Motley Fool
-
1 Wall Street Analyst Thinks Apple Stock Is Going to $210. Is It a Buy Around $182?
Motley Fool
Advertisement
More coverage
Symbotic Stock Is Headed to $58, According to 1 Wall Street Analyst. Is It a Buy?
Motley Fool
A price target of $58 might seem like a stretch, but the evidence suggests the artificial intelligence (AI)-powered warehouse..
-
1 Wall Street Analyst Thinks McDonald's Stock Is Going to $310. Is It a Buy Around $270?
Motley Fool
-
1 Wall Street Analyst Thinks Coinbase Global Stock Is Going to $240. Is It a Buy?
Motley Fool
-
1 Wall Street Analyst Thinks Alphabet Stock Is Going to $200. Is It a Buy?
Motley Fool
-
1 Wall Street Analyst Thinks DraftKings Stock Is Going to $52. Is It a Buy Around $42?
Motley Fool